This inventor holds 27 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Cancer Treatment Technologies. Top assignees: Cellectricon Ab, Oblique Therapeutics Ab, Fluicell Ab. Active years: 2002-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Göteborg, SE (2002 - 2006)
- Hovás, SE (2012)
- Hovås, SE (2002 - 2024)
- Hovas, SE (2012 - 2024)
Company Filing History:
13 out of 15 
5 out of 8 
4 out of 4 
Years Active: 2002-2026
Areas of Expertise:
Title: Owe Orwar: Innovator in Biotechnology and Drug Development
Introduction
Owe Orwar is a prominent inventor based in Hovås, Sweden, with an impressive portfolio boasting 25 patents. His work primarily focuses on innovative solutions in biotechnology and pharmaceuticals, particularly in cell printing technologies and cancer treatments.
Latest Patents
Among Orwar's latest inventions is a groundbreaking patent for "Cell printing utilizing recirculating fluid flows." This invention presents a sophisticated system designed for dispensing and printing cells and particles. The apparatus includes a flow confinement device, a controller that generates confined liquid volumes, and one or more liquids containing cells or cell constituents. This system enables the confined liquid volume to interact with a substrate in precisely controlled ways, allowing for advanced applications in tissue engineering.
Another significant recent patent involves a "Pharmaceutical combination for the treatment of cancer." This invention comprises a combination of a CDK inhibitor and at least one antioxidant enzyme inhibitor aimed at treating cancer. The method introduces a synergistic effect that enhances therapeutic outcomes for subjects requiring treatment, marking a notable advancement in oncology.
Career Highlights
Owe Orwar has contributed to several reputable companies in the biotech field, including Cellectricon AB and Oblique Therapeutics AB. His work has not only been instrumental in developing innovative technologies but has also paved the way for new therapeutic interventions in complex medical conditions.
Collaborations
Throughout his career, Orwar has collaborated with distinguished professionals, including Daniel T. Chiu and Mattias Karlsson. Their teamwork has fostered an environment of innovation and expertise, further enhancing the impact of their collective research and development efforts.
Conclusion
Owe Orwar stands out as a significant figure in the realms of biotechnology and drug development. His numerous patents reflect his dedication to advancing medical technologies and improving patient outcomes, making him a valuable asset to the scientific community and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile